(Reuters) - Analysts and investors are awaiting details behind UnitedHealth Group's 2025 outlook when it reports quarterly ...

Three major drug middlemen needlessly marked up generic drugs for cancer, HIV, and multiple sclerosis to generate $7.3 ...

This was the stock's second consecutive day of gains.

San Francisco and its hotel industry are partnering to beef up security around this week's 43rd annual J.P. Morgan Healthcare ...

Key Takeaways UnitedHealth Group is set to report fourth-quarter earnings before the market opens Thursday.All 17 analysts ...

UnitedHealth's valuation metrics indicate a potential buy-the-dip opportunity, with forward ratios mostly below their ...

Anger at the company, and the health insurance industry more broadly, boiled over last month following the murder of ...

The stock's fall snapped a four-day winning streak.

The slain CEO of the insurer had a vision for positive change; his company should embrace new consumer remedies, writes .

Shareholders of UnitedHealth Group (UHG) are calling on the company’s board of directors to release a report on how its ...

UnitedHealth Chief Executive Andrew Witty stated the obvious when he wrote last month that no one would design a healthcare ...

We recently published a list of 12 Best Safe Dividend Stocks for 2025. In this article, we are going to take a look at where ...